If you were a Dividend.com Premium member, you would be seeing detailed DARS™ Dividend Stock Ratings information for Pfizer (PFE) in this space. Sign up for Dividend.com Premium today to gain access to ratings on nearly 2,000 dividend-paying stocks, exclusive members-only articles, historical dividend information, and more!
Pfizer (PFE) - pharmaceutical name that has struggled with lack of new blockbuster drugs lately. A dividend has been paid since 1901, and raised each year since 1968. Its Pharmaceutical segment offers products for cardiovascular and metabolic diseases, such as Lipitor for elevated cholesterol levels in the blood; Norvasc for hypertension; Caduet for cardiovascular events; Chantix/Champix for smoking cessation; and Exubera, the inhaled human insulin therapy for glycemic control. Its products for central nervous system disorders include Zoloft for various disorders; Geodon/Zeldox, a psychotropic agent; Aricept for Alzheimer's disease; and Lyrica for adjuctive therapy for adults with partial onsent epileptic seizures. This segment also offers Celebrex for osteoarthritis, adult rheumatoid arthritis, acute pain, menstrual pain, and familial adenomatous polyposis; Zithromax for bacterial infections; Vfend for serious and potentially fatal fungal infections, esophageal candidiasis, and blood stream infections in non-neutropenic patients; Zyvox for bacterial infections; and Viagra for erectile dysfunction; and Detrol for overactive bladder. In addition, it offers Camptosar, a therapy for metastatic colorectal cancer; Sutent, an oral multi-kinase inhibitor; Xalatan/Xalacom for open-angle glaucoma and ocular hypertension; Genotropin for various growth disorders; and Zyrtec for allergies and hives. The company was founded in 1849 and is headquartered in New York, New York.
* Stock price reflects previous day's closing price. All stock quotes on this website should be considered as having a 24-hour delay.
** Under no circumstances does the information in this column represent a recommendation to buy or sell stocks. The author is not registered as an investment adviser. The author may or may not hold positions in the securities mentioned in this article or video. The author relies upon the "publisher's exclusion" from the definition of "investment adviser" as provided under Section 202(a)(11) of the Investment Advisers Act of 1940 and corresponding state securities laws.
*** All dividend payout and date information on this website is for information purposes only. We do not guarantee the accuracy of any dividend dates or payout amounts. Always check with your broker first before purchasing any security.
OFFERS FROM OUR SPONSORS
DIRECT COMPETITORS
The following dividend stocks are considered direct competitors of Pfizer (PFE):
Stock Screener
Add PFE to My Watchlist »
View Historical Dividend Data for PFE »
Company Profile
OFFERS FROM OUR SPONSORS
DIRECT COMPETITORS
RELATED COMPANIES
MORE RESEARCH
RSS Feeds